Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy

Hepatitis C is a common and potentially serious disease. However, there are treatments that can cure it. That's why it's so important to detect the hepatitis C virus (HCV) and treat those affected. Today, many hepatitis C sufferers in Cameroon (and elsewhere) remain untreated. The aim of this research is therefore to evaluate a simplified screening and treatment strategy (developed specifically for the Cameroonian context) in comparison with a standard strategy (based on usual care), in order to improve access to hepatitis C treatment in Cameroon. If the results of this research are positive, this strategy could be recommended to health authorities in Cameroon and other comparable countries.

NCT Number	NCT07098481
Lead Sponsor	ANRS, Emerging Infectious Diseases Collaborators: IRD, Epidemiologie et Prevention, Montpelier, France, SESSTIM (IRD, Inserm, Université Aix-Marseille), Centre de Recherche sur les Maladies Emergentes et Re-Emergentes (CREMER), Faculté de Médecine et des Sciences Biomédicales, Université de Yaoundé I, Yaoundé, Cameroun, PharmAccess, Service d'hépato-gastroentérologie, Hôpital Saint Joseph, Marseille, France
Conditions	Hepatitis C Virus Infection
Enrollment	576 participants
Start Date	2025-09-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-08-01